MedEdge Innovations (MEI), a leading developer of advanced medical materials and device technologies, today announced the official launch of its medical implant-grade expanded polytetrafluoroethylene (ePTFE) product line and comprehensive customized CDMO (Contract Development and Manufacturing Organization) services via a new digital platform:www.meimedtech.com
This strategic expansion marks a major milestone in MEI’s ongoing mission to provide high-performance, customized medical solutions to device manufacturers worldwide.
Backed by more than a decade of innovation and engineering excellence, MEI leverages proprietary manufacturing processes and deep materials science expertise to deliver premium ePTFE components — including membranes, tubing, and ultra-thin tubing — tailored for cardiovascular, peripheral vascular, general surgery, and other life-saving applications.
“The launch of our ePTFE platform and CDMO services is a natural extension of MEI’s commitment to innovation, quality, and global collaboration,” said Tony Liu, CEO of MedEdge Innovations. “Through www.meimedtech.com, we are making our high-performance ePTFE materials more accessible to medical device innovators seeking reliability, scalability, and customization.”
Key Highlights of MEI’s ePTFE and CDMO Capabilities:
- Precision-engineered ePTFE membranes, tubes, ultra-thin tubing, and specialized components
- Endoscopic biopsy channel solutions
- Fully customizable CDMO services
- Rapid prototyping and scalable manufacturing
- ISO 13485–certified quality management system
- Biocompatibility for implant-grade applications
With the new platform, MEI aims to become a go-to partner for medical technology companies seeking biomaterials with superior durability, flexibility, and biocompatibility for both R&D and large-scale production.
